financetom
Business
financetom
/
Business
/
Here are the Indian companies which have been impacted by protests in China
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Here are the Indian companies which have been impacted by protests in China
Nov 29, 2022 9:06 AM

1. Gland Pharma | The shares of the pharma company jumped 9.3 percent after Bloomberg reported that billionaire Guo Guangchang’s Shanghai Fosun Pharmaceutical Group Co is considering a sale of the Indian drugmaker after receiving interest from potential buyers. However later, Gland Pharma clarified that the company is not aware of any such development.

2. Tata Motors Ltd | China is a key market for Tata Motors' UK-unit Jaguar Land Rover. During the September quarter, China sales accounted for 31 percent of the overall JLR segment, including the China JV. However, the country is currently battling record COVID cases and strong protests against the government. The shares of the automotive company fell 0.8 percent on Tuesday.

3. Voltas Ltd | Indian companies depend on China for 10-20 percent of AC components like compressors and controllers. The shares of the AC company fell as much as 1.8 percent on Tuesday.

4. Caplin Point Laboratories | According to the company, the China accounts for 40 percent of its total exports. The shares fell 1.8 percent on Tuesday.

5. Aurobindo Pharma | The company procures around 55percent of the raw material from China to meet its requirement of APIs and excipients production. Shares of the pharmaceutical giant closed at Rs 466 a unit, down by 0.21 percent from the previous close on the BSE.

6. VIP Industries | VIP Industries manufactures luggage and travel accessories in India. Around 50 percent of the company's manufacturing is done in China. Chinese suppliers account for a majority of VIP's revenue from soft luggage. Shares of VIP closed at Rs 728 a unit, down by 0.4 percent, from the previous close on the BSE.

7 Dr Reddys Laboratories | The Hyderabad based pharma company operates in China through a joint venture with the Rotam Group of Canada. Shares closed rising 1.16 percent on Tuesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Legislative
Legislative "roadmap" for AI coming in weeks, Schumer says
May 8, 2024
WASHINGTON, May 8 (Reuters) - Senate Majority Leader Chuck Schumer said on Wednesday he would provide a roadmap for artificial intelligence in the coming weeks that will be translated into legislation. ...
Update: Market Chatter: Amazon Enters Europe 5G Networks Via Telefonica Germany Deal
Update: Market Chatter: Amazon Enters Europe 5G Networks Via Telefonica Germany Deal
May 8, 2024
10:31 AM EDT, 05/08/2024 (MT Newswires) -- (Updates with additional details throughout.) Amazon.com ( AMZN ) has struck a deal with Telefonica Germany that will see Telefonica move 1 million 5G customers to Amazon Web Services' cloud later this month, Reuters reported. I want to see it working for at least one to two quarters and have a roadmap to...
Pfizer agrees to settle more than 10,000 Zantac cancer lawsuits - Bloomberg News
Pfizer agrees to settle more than 10,000 Zantac cancer lawsuits - Bloomberg News
May 8, 2024
May 8 (Reuters) - Pfizer Inc ( PFE ) has agreed to settle more than 10,000 cases about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal. (Reporting by Leroy Leo in Bengaluru; Editing by Devika Syamnath) ...
Update: Market Chatter: Pfizer to Settle More Than 10,000 Zantac Cancer Lawsuits
Update: Market Chatter: Pfizer to Settle More Than 10,000 Zantac Cancer Lawsuits
May 8, 2024
10:35 AM EDT, 05/08/2024 (MT Newswires) -- (Updates with additional details in the last three paragraphs.) Pfizer ( PFE ) has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks associated with its Zantac heartburn drug, Bloomberg reported Wednesday, citing people familiar with the matter. The agreements cover cases in state courts across the country...
Copyright 2023-2026 - www.financetom.com All Rights Reserved